PassOncology is an independent educational resource for FRCR Part 1 Clinical Oncology revision. It is not provided, approved, endorsed, or sponsored by The Royal College of Radiologists (RCR), the GMC, the NHS, or any training programme, deanery, hospital, or examination body.
All questions, explanations, summaries, analytics, and AI-generated outputs on this platform are provided for private study and general educational use only. They are not official examination materials, are not reproduced from any live or confidential examination, and are not intended to predict, replicate, or disclose the content of any actual FRCR examination.
Our questions are developed using AI-assisted drafting, then reviewed, edited and approved by clinicians who have passed the FRCR Clinical Oncology Part 1 exams.
PassOncology does not guarantee examination success, any particular score, progression outcome, or training result. Examination formats, curricula, weighting, guidance, and standards may change at any time. Users remain responsible for consulting the current official RCR curriculum, regulations, and published guidance.
Nothing on this platform constitutes medical advice, treatment advice, radiation oncology advice, professional advice, or clinical instruction for any specific patient. The content must not be used as a substitute for clinical judgment, supervision, local protocols, multidisciplinary discussion, manufacturer guidance, or up-to-date primary sources. No clinical decision should be made solely on the basis of content from this platform.
Where clinical concepts, drug information, radiobiology principles, statistics, or physics topics are discussed, they are simplified for examination preparation. Errors, omissions, outdated material, or differences of interpretation may exist. Users must independently verify important information before relying on it in academic, professional, or clinical settings.
Any references to trainees, specialists, educators, or contributors describe backgrounds only and do not imply examiner status, institutional endorsement, or representation of any regulator, employer, college, or public body.
All trademarks, logos, and organisation names remain the property of their respective owners. Any reference to FRCR, RCR, GMC, NHS, or other third parties is for identification and descriptive purposes only and does not imply affiliation or endorsement.
By using PassOncology, you accept that the platform is provided on an "as is" and "as available" basis for educational use only.
